BCM
CVS icon

Bourgeon Capital Management’s CVS Health CVS Stock Holding History

Bourgeon Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-129,002
Closed -$7.62M – 107
2024
Q2 		$7.62M Buy
129,002
+9,737
+8% +$609K 1.49% 30
2024
Q1 		$9.51M Sell
119,265
-7
-0% -$535 1.86% 21
2023
Q4 		$9.42M Sell
119,272
-275
-0.2% -$19.6K 2.08% 17
2023
Q3 		$8.35M Buy
119,547
+58,761
+97% +$4.16M 1.96% 20
2023
Q2 		$4.2M Sell
60,786
-121
-0.2% -$8.61K 0.98% 38
2023
Q1 		$4.53M Buy
60,907
+130
+0.2% +$10.9K 1.08% 38
2022
Q4 		$5.66M Sell
60,777
-60,451
-50% -$5.83M 1.39% 30
2022
Q3 		$11.6M Buy
121,228
+30
+0% +$2.97K 3.18% 6
2022
Q2 		$11.2M Buy
121,198
+918
+0.8% +$89.6K 2.97% 8
2022
Q1 		$12.2M Sell
120,280
-34,220
-22% -$3.59M 2.75% 13
2021
Q4 		$15.9M Buy
154,500
+126
+0.1% +$11.6K 3.28% 5
2021
Q3 		$13.1M Buy
154,374
+561
+0.4% +$47K 2.8% 9
2021
Q2 		$12.8M Sell
153,813
-33,880
-18% -$2.77M 2.76% 9
2021
Q1 		$14.1M Buy
187,693
+315
+0.2% +$22.9K 3.13% 3
2020
Q4 		$12.8M Buy
187,378
+93
+0% +$6.05K 3.16% 4
2020
Q3 		$10.9M Buy
187,285
+37,997
+25% +$2.36M 3.31% 7
2020
Q2 		$9.7M Buy
149,288
+11,917
+9% +$750K 3.45% 5
2020
Q1 		$8.15M Buy
137,371
+26,520
+24% +$1.77M 4.22% 2
2019
Q4 		$8.23M Sell
110,851
-6,550
-6% -$460K 3.89% 5
2019
Q3 		$7.4M Buy
117,401
+2,247
+2% +$133K 4.01% 6
2019
Q2 		$6.28M Buy
115,154
+39,700
+53% +$2.14M 3.64% 6
2019
Q1 		$4.07M Buy
75,454
+19,454
+35% +$1.2M 2.39% 19
2018
Q4 		$3.67M Buy
+56,000
New +$4.18M 2.4% 21

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Bourgeon Capital Management's CVS Position: Q3 2024 in Review

Bourgeon Capital Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 129,002 shares — an estimated $7.62M sold.

Bourgeon Capital Management first reported a position in CVS in Q4 2018 and held it in 23 quarters. The position peaked at $15.9M in Q4 2021. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Bourgeon Capital Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Bourgeon Capital Management sold 129,002 CVS Health shares in Q3 2024, an estimated $7.62M.
  • Bourgeon Capital Management first reported a position in CVS Health in Q4 2018 and held it in 23 quarters.
  • Bourgeon Capital Management's CVS Health position peaked at $15.9M in Q4 2021.
  • 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Bourgeon Capital Management's 13F filing for Q3 2024, filed 16 Oct 2024.